We identify the undiagnosed.
Our clinical platform allows physicians to maximize the effectiveness of their EMRs while maintaining control of patient data. We put the power to identify and assess patients with rare conditions at the physician’s fingertips.
Advanced clinical dashboards and deep analytical tools allow physicians to quickly understand complex, high-risk, rare disease patients and identify the right care pathways.
Eliminate hours of cumbersome manual research trying to map conditions to your complex patients.
Quickly synthesize complex patient details and rare disease clinical criteria to identify high-risk patients.
Optimize diagnosis and referral pathways to ensure comprehensive care.
- Identify target rare disease patients using global clinical research and deep analytics
- Match high-risk patients with the right care pathway
- Support the patient-provider journey to ensure optimal treatment
- Accelerate rare disease patient identification for clinical studies
Protecting the security and privacy of our customers’ data and their patient data is paramount for Khure Health. This includes complying with Canadian Data Protection regulations, including the Personal Information Protection and Electronic Documents Act (PIPEDA) and the Personal Health Information Protection Act (PHIPA). Your patient data never leaves your office.
Khure Health is a great resource to my practice. It provides insights into rare diseases that I probably would not have considered. It provides a short list of patients to consider for rare diseases by searching my clinical database, recommends the next steps, and provides the necessary education material to make an appropriate clinical decision
Dr. Andrew Vellathottam MD, CFPC - Scarborough, Ontario
... Advanced AI-enabled Solutions, such as tech like Khure Health's clinical intelligence platform, harnesses the power of artificial intelligence [AI] to capitalize on the vast amounts of patient data in EMRs, enabling the potential diagnosis and hopefully improved treatment and quality of life for the patient. It is anticipated that identification of rare disease in patients and care pathway optimization technologies will play an even larger role in clinical decision support in the future.
Dr. David Price MD, CCFP, FCFP - Hamilton, Ontario
The Khure Health program helped me successfully identify a patient in my practice who was undiagnosed and suffering from Hereditary Spherocytosis. I am happy to say this patient is now working with a specialist to get the care they need. We need more tools like this to help us quickly and efficiently identify undiagnosed or misdiagnosed patients within our practices. With early identification and intervention, I now have the ability to better serve my patients. The Khure Health team was wonderful in supporting me throughout this process, and helped me easily understand my options for next steps in my patient's care.
Dr. Fadie Amin MD - Toronto, Ontario
Previous
Next